Litcius/Paper detail

Isolation of tumor-infiltrating lymphocytes from preserved human tumor tissue specimens for downstream characterization

Tamiyo Kobayashi, Shogo Kumagai, Rieko Doi, Elena Afonina, Shohei Koyama, Hiroyoshi Nishikawa

2022STAR Protocols19 citationsDOIOpen Access PDF

Abstract

Immunophenotyping of tumor-infiltrating lymphocytes (TILs) by flow cytometry can predict clinical efficacy of immunotherapy. However, several obstacles need to be overcome for developing a flow cytometry assay starting from solid tumor specimens. Here, we show a detailed enzyme-based protocol to isolate TILs from human tumor tissues. The protocol was optimized to obtain enough viable TILs from a biopsy tissue specimen for flow cytometry-based TIL immunophenotyping. Additionally, tissue samples could be preserved for up to 72 h for subsequent characterization. For complete details on the use and execution of this protocol, please refer to Kumagai et al. (2020, 2022).

Topics & Concepts

ImmunophenotypingFlow cytometryTumor-infiltrating lymphocytesPathologyImmunotherapyBiopsyTumor cellsCytometryCancer researchBiologyMedicineMolecular biologyImmune systemImmunologyImmune Cell Function and InteractionImmunotherapy and Immune ResponsesCancer Immunotherapy and Biomarkers